Identification of patient characteristics associated with survival benefit from metformin treatment in patients with stage I non–small cell lung cancer-Reference-Cited by-同舟云学术

Identification of patient characteristics associated with survival benefit from metformin treatment in patients with stage I non–small cell lung cancer

Published:2022-11 Issue:5 Volume:164 Page:1318-1326.e3
ISSN:0022-5223
Container-title:The Journal of Thoracic and Cardiovascular Surgery
language:en
Short-container-title:The Journal of Thoracic and Cardiovascular Surgery

Author:

Elkin Peter L.,Mullin Sarah,Tetewsky Sheldon,Resendez Skyler D.,McCray Wilmon,Barbi Joseph,Yendamuri Sai

Funder

National Institute on Alcohol Abuse and Alcoholism

U.S. National Library of Medicine

U.S. Department of Veterans Affairs

National Center for Advancing Translational Sciences

National Institutes of Health

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference43 articles.

1. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours;Goldstraw;J Thorac Oncol,2007

2. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer;Arriagada;N Engl J Med,2004

3. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group;Pignon;J Clin Oncol,2008

4. Treatment capacity required for full-scale implementation of lung cancer screening in the United States;Blom;Cancer,2019

5. Metformin–mode of action and clinical implications for diabetes and cancer;Pernicova;Nat Rev Endocrinol,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Body mass index, weight change, and cancer prognosis: a meta-analysis and systematic review of 73 cohort studies;ESMO Open;2024-03